Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK: experience from the ActWELL trial

Hanne Bruhn; Annie S. Anderson; Amy Hickman; E. Jane Macaskill; Shaun Treweek

doi:10.1186/s13063-021-05340-3

Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK: experience from the ActWELL trial

Hanne Bruhn (Lead / Corresponding author), Annie S. Anderson, Amy Hickman, E. Jane Macaskill, Shaun Treweek

Population Health and Genomics

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

104 Downloads (Pure)

Abstract

After the SARS-CoV-2 pandemic took hold in the UK the ActWELL trial team’s plans to present the trial results to participants and other stakeholders had to change. Instead of face-face events, three online events were planned and hosted successfully. In this article we describe the choices made in planning and organisation of the online events including things we would do differently if we were to do it again. We think that online events are a useful platform when informing participants and other stakeholders of the results of your trial, even beyond the SARS-CoV-2 pandemic and we hope this article can help other trial teams to plan their own online events.

Original language	English
Article number	381
Number of pages	5
Journal	Trials
Volume	22
DOIs	https://doi.org/10.1186/s13063-021-05340-3
Publication status	Published - 5 Jun 2021

Keywords

COVID-19
Online events
Randomised trials
Research transparency
Result dissemination
Trial conduct

ASJC Scopus subject areas

Medicine (miscellaneous)
Pharmacology (medical)

Access to Document

10.1186/s13063-021-05340-3Licence: CC BY

Final Published VersionFinal published version, 495 KBLicence: CC BY

Cite this

@article{81c903802cf74ce7ba90357649113bcf,

title = "Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK: experience from the ActWELL trial",

abstract = "After the SARS-CoV-2 pandemic took hold in the UK the ActWELL trial team{\textquoteright}s plans to present the trial results to participants and other stakeholders had to change. Instead of face-face events, three online events were planned and hosted successfully. In this article we describe the choices made in planning and organisation of the online events including things we would do differently if we were to do it again. We think that online events are a useful platform when informing participants and other stakeholders of the results of your trial, even beyond the SARS-CoV-2 pandemic and we hope this article can help other trial teams to plan their own online events.",

keywords = "COVID-19, Online events, Randomised trials, Research transparency, Result dissemination, Trial conduct",

author = "Hanne Bruhn and Anderson, {Annie S.} and Amy Hickman and Macaskill, {E. Jane} and Shaun Treweek",

note = "Funding Information: We would like to thank our ActWELL participants who attended the events for their interest and enthusiasm in making the events a success. We would like to thank Susan MacAskill for giving us permission to use a quote from her email to us. We are also grateful to the technical support who got us through all events, Cormac Staunton (of stauntonmedia.ie). We would also like to acknowledge and thank Dr Katie Gillies and Dr Seonaidh Cotton for their contribution to the design of the evaluation survey. HSRU is core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates. Funding Information: This work was supported by The Scottish Government, grant number BC/Screening/17/01. Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2021",

month = jun,

day = "5",

doi = "10.1186/s13063-021-05340-3",

language = "English",

volume = "22",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central",

}

TY - JOUR

T1 - Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK

T2 - experience from the ActWELL trial

AU - Bruhn, Hanne

AU - Anderson, Annie S.

AU - Hickman, Amy

AU - Macaskill, E. Jane

AU - Treweek, Shaun

N1 - Funding Information: We would like to thank our ActWELL participants who attended the events for their interest and enthusiasm in making the events a success. We would like to thank Susan MacAskill for giving us permission to use a quote from her email to us. We are also grateful to the technical support who got us through all events, Cormac Staunton (of stauntonmedia.ie). We would also like to acknowledge and thank Dr Katie Gillies and Dr Seonaidh Cotton for their contribution to the design of the evaluation survey. HSRU is core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates. Funding Information: This work was supported by The Scottish Government, grant number BC/Screening/17/01. Publisher Copyright: © 2021, The Author(s).

PY - 2021/6/5

Y1 - 2021/6/5

N2 - After the SARS-CoV-2 pandemic took hold in the UK the ActWELL trial team’s plans to present the trial results to participants and other stakeholders had to change. Instead of face-face events, three online events were planned and hosted successfully. In this article we describe the choices made in planning and organisation of the online events including things we would do differently if we were to do it again. We think that online events are a useful platform when informing participants and other stakeholders of the results of your trial, even beyond the SARS-CoV-2 pandemic and we hope this article can help other trial teams to plan their own online events.

AB - After the SARS-CoV-2 pandemic took hold in the UK the ActWELL trial team’s plans to present the trial results to participants and other stakeholders had to change. Instead of face-face events, three online events were planned and hosted successfully. In this article we describe the choices made in planning and organisation of the online events including things we would do differently if we were to do it again. We think that online events are a useful platform when informing participants and other stakeholders of the results of your trial, even beyond the SARS-CoV-2 pandemic and we hope this article can help other trial teams to plan their own online events.

KW - COVID-19

KW - Online events

KW - Randomised trials

KW - Research transparency

KW - Result dissemination

KW - Trial conduct

UR - http://www.scopus.com/inward/record.url?scp=85107203204&partnerID=8YFLogxK

U2 - 10.1186/s13063-021-05340-3

DO - 10.1186/s13063-021-05340-3

M3 - Article

C2 - 34090495

SN - 1745-6215

VL - 22

JO - Trials

JF - Trials

M1 - 381

ER -

Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK: experience from the ActWELL trial

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

A Randomised Control Trial to Assess the Impact of a Lifestyle Intervention (ActWELL) in Women Attending Breast Screening Clinics

Cite this

Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK: experience from the ActWELL trial

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Projects

A Randomised Control Trial to Assess the Impact of a Lifestyle Intervention (ActWELL) in Women Attending Breast Screening Clinics

Cite this